Please login to the form below

Not currently logged in
Email:
Password:

idelalisib

This page shows the latest idelalisib news and features for those working in and with pharma, biotech and healthcare.

FDA approves Gilead drug in three blood cancers

FDA approves Gilead drug in three blood cancers

The FDA recommended the use of Zydelig ( idelalisib) in combination with Roche's Rituxan ( rituximab) to treat patients with relapsed chronic lymphocytic leukaemia.

Latest news

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Taylor James

Taylor James is a creative production studio working at the forefront of content production. Headquartered in London, we deliver award...

Latest intelligence

UK life sciences minister George Freeman
Creating a 21st century life sciences ecosystem
The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation...
Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...
Online Physician Communities
How can pharma innovate in child and TYA cancer?
by Dr Tim Ringrose, M3 (EU)...